Literature DB >> 22494099

Recruitment of circulating dendritic cell precursors into the infarcted myocardium and pro-inflammatory response in acute myocardial infarction.

Daniel Kretzschmar1, Stefan Betge, Alexander Windisch, Rudin Pistulli, Ilonka Rohm, Michael Fritzenwanger, Christian Jung, Katja Schubert, Bernhard Theis, Iver Petersen, Stefanie Drobnik, Gita Mall, Hans-Reiner Figulla, Atilla Yilmaz.   

Abstract

DC (dendritic cells) play an important role in the immune system. They invade peripheral tissues to detect harmful antigens, inducing a local immune response. Studies suggest that DCPs (dendritic cell precursors) might be reduced in AMI (acute myocardial infarction); however, the reason for their reduction is unknown yet. In the present study, circulating mDCPs (myeloid DCPs), pDCPs (plasmacytoid DCPs), tDCPs (total DCPs) and serum levels of TNFα (tumour necrosis factor α), IL (interleukin)-2, -4, -5, -6, -10 and -12 were analysed by flow cytometry in blood of patients with NSTEMI [non-STEMI (ST-segment elevation myocardial infarction)] (n=44) and STEMI (n=34) compared with controls with excluded CAD (coronary artery disease) (n=45). Post-mortem myocardial specimens of patients with AMI (n=12) and healthy myocardium of accident victims (n=10) were immunostained for mDCs (myeloid dendritic cells) T-cells and macrophages. Compared with controls, in patients with AMI a significant decrease in circulating mDCPs, pDCPs and tDCPs was observed (each P<0.0001). The extent of the decrease was higher in STEMI than NSTEMI patients. Serum levels were significantly higher in patients with AMI compared with controls for IL-6, -10, -12 and TNFα (each P<0.03). Immunostaining revealed significantly higher number of DCs, T-cells and macrophages (each P<0.002) in infarcted than control myocardium. We show that circulating DCPs are significantly reduced in AMI, with a pronounced reduction in STEMI patients. This was accompanied by a significant increase of inflammatory serum cytokines in patients with AMI. Immunohistochemical analysis unravelled that the reduction of circulating DCPs might be due to recruitment into the infarcted myocardium.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22494099     DOI: 10.1042/CS20110561

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  25 in total

Review 1.  Dendritic cells and isolevuglandins in immunity, inflammation, and hypertension.

Authors:  Kala B Dixon; Sean S Davies; Annet Kirabo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-12-16       Impact factor: 4.733

Review 2.  Immune cell diversity contributes to the pathogenesis of myocarditis.

Authors:  Xiumeng Hua; Jiangping Song
Journal:  Heart Fail Rev       Date:  2019-11       Impact factor: 4.214

Review 3.  Inflammation and hypertension: new understandings and potential therapeutic targets.

Authors:  Carmen De Miguel; Nathan P Rudemiller; Justine M Abais; David L Mattson
Journal:  Curr Hypertens Rep       Date:  2015-01       Impact factor: 5.369

Review 4.  Exploring the Mechanisms Underlying the Cardiotoxic Effects of Immune Checkpoint Inhibitor Therapies.

Authors:  Daniel Ronen; Aseel Bsoul; Michal Lotem; Suzan Abedat; Merav Yarkoni; Offer Amir; Rabea Asleh
Journal:  Vaccines (Basel)       Date:  2022-03-31

5.  Transient decrease in human peripheral blood myeloid dendritic cells following influenza vaccination correlates with induction of serum antibody.

Authors:  James J Kobie; John J Treanor; Christopher T Ritchlin
Journal:  Immunol Invest       Date:  2014       Impact factor: 3.657

6.  Decrease in circulating dendritic cell precursors in patients with peripheral artery disease.

Authors:  Daniel Kretzschmar; Ilonka Rohm; Sebastian Schäller; Stefan Betge; Rudin Pistulli; Yevgeniya Atiskova; Hans-R Figulla; Atilla Yilmaz
Journal:  Mediators Inflamm       Date:  2015-04-15       Impact factor: 4.711

Review 7.  Dendritic Cells and Their Role in Cardiovascular Diseases: A View on Human Studies.

Authors:  Maja-Theresa Dieterlen; Katja John; Hermann Reichenspurner; Friedrich W Mohr; Markus J Barten
Journal:  J Immunol Res       Date:  2016-03-20       Impact factor: 4.818

Review 8.  Immune regulation of cardiac fibrosis post myocardial infarction.

Authors:  Yusra Zaidi; Eslie G Aguilar; Miguel Troncoso; Daria V Ilatovskaya; Kristine Y DeLeon-Pennell
Journal:  Cell Signal       Date:  2020-11-15       Impact factor: 4.850

9.  Circulating dendritic cell precursors in chronic kidney disease: a cross-sectional study.

Authors:  Katharina Paul; Daniel Kretzschmar; Atilla Yilmaz; Barbara Bärthlein; Stephanie Titze; Gunter Wolf; Martin Busch
Journal:  BMC Nephrol       Date:  2013-12-10       Impact factor: 2.388

10.  Decreased myocardial dendritic cells is associated with impaired reparative fibrosis and development of cardiac rupture after myocardial infarction in humans.

Authors:  Toshiyuki Nagai; Satoshi Honda; Yasuo Sugano; Taka-aki Matsuyama; Keiko Ohta-Ogo; Yasuhide Asaumi; Yoshihiko Ikeda; Kengo Kusano; Masaharu Ishihara; Satoshi Yasuda; Hisao Ogawa; Hatsue Ishibashi-Ueda; Toshihisa Anzai
Journal:  J Am Heart Assoc       Date:  2014-06-03       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.